Sen. Elizabeth Warren (D-MA) is calling on the Federal Trade Commission to carefully evaluate Novo Nordisk Foundation's ...

On Monday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.61 which represents a slight increase of $0.02 or 0.03% from the prior close of $60.59. The stock opened at $60.53 and ...

Catalent Inc (CTLT) stock saw a decline, ending the day at $60.59 which represents a decrease of $-0.12 or -0.20% from the prior close of $60.71. The stock opened at $60.75 and touched a low of $60.5 ...

SOMERSET, N.J., August 29, 2024--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for ...

Fintel reports that on September 24, 2024, Baird downgraded their outlook for Catalent (NYSE:CTLT) from Outperform to Neutral ...

Investors interested in stocks from the Medical - Drugs sector have probably already heard of Takeda Pharmaceutical Co. (TAK) and Catalent (CTLT). But which of these two stocks is more attractive ...

U.S. Senator Elizabeth Warren has asked antitrust regulators to closely scrutinize a $16.5 billion deal in which Novo Nordisk ...

Robert W. Baird analyst Eric Coldwell downgraded the rating on Catalent (CTLT – Research Report) to a Hold today, setting a price target ...